{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:45:58Z","timestamp":1772081158976,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T00:00:00Z","timestamp":1157500800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Botulinum toxin type A is a neurotoxin produced by the bacterium <jats:italic>Clostridium botulinum<\/jats:italic> which causes a flaccid muscle paralysis. It has been used extensively in the field of dermatology for the treatment of dynamic rhytides and in the treatment of hyperhidrosis. Botulinum toxin has an excellent safety profile and few side effects when used for these purposes. Recently, botulinum toxin has also been used experimentally in a number of other dermatologic conditions with good results. These conditions include: persistent facial flushing, gustatory sweating and epiphora, anal fissures, familial benign pemphigus (Hailey\u2010Hailey disease), dyshidrotic eczema, and following surgical wound closures. While randomized, controlled prospective trials are still needed to further understand the efficacy and safety of botulinum toxin in these conditions, anecdotal and case report data suggest that botulinum toxin is both safe and efficacious in these and many other procedures.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2006.00255.x","type":"journal-article","created":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T15:51:27Z","timestamp":1157557887000},"page":"268-272","source":"Crossref","is-referenced-by-count":20,"title":["Novel cutaneous uses for botulinum toxin type A"],"prefix":"10.1111","volume":"5","author":[{"given":"Cheryl","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny J","family":"Omlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,9,6]]},"reference":[{"key":"e_1_2_10_2_2","unstructured":"Neer K. What is Botox? URL:http:\/\/health.howstuffworks.com\/botox1.htm. Accessed 2006 Copyright HSW Media Network a Convex Company Atlanta Georgia."},{"key":"e_1_2_10_3_2","unstructured":"About Myobloc.URL:http:\/\/www.myobloc.com\/hp_about\/about.html. Accessed 2005 Copyright Solstice Neurosciences Inc. South San Francisco CA."},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105567"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2003.29120.x"},{"key":"e_1_2_10_6_2","unstructured":"BOTOX\u00ae(Botulinum Toxin Type A) Purified Neurotoxin Complex.URL:http:\/\/www.rxlist.com\/cgi\/generic3\/botox.htm. Accessed January 2005 Copyright 2006 by RxList Inc."},{"key":"e_1_2_10_7_2","unstructured":"Trizna Z. Botulinum Toxin.URL:http:\/\/www.emedicine.com\/derm\/topic779.htm. Accessed August 2005 Copyright 2006 by WebMD."},{"key":"e_1_2_10_8_2","unstructured":"Botulism. URL:http:\/\/www.cdc.gov\/ncidod\/dbmd\/diseaseinfo\/botulism_g.htm. Accessed October 2005 Content source: Coordinating Center for Infectious Diseases\/Division of Bacterial and Mycotic Diseases. Copyright 2006 Centers for Disease Control."},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1998.9"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30017.x"},{"key":"e_1_2_10_11_2","first-page":"533","volume-title":"Cutaneous Medicine and Surgery","author":"Wilkin MK","year":"1996"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(00)70246-4"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-200007000-00007"},{"key":"e_1_2_10_14_2","unstructured":"Anal Fissure.URL:http:\/\/www.fascrs.org\/displaycommon.cfm?an=1&subarticlenbr=3. Accessed 2003 Content source: American Society of Colon and Rectal Surgeons."},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2005.03427.x"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05068.x"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12331167"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00658.x"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2000.99278.x"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170160260762"},{"key":"e_1_2_10_21_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00042728-200206000-00025","article-title":"Botulinum toxin A as an effective adjuvant therapy for Hailey\u2010Hailey disease","volume":"28","author":"Kang NG","year":"2002","journal-title":"Dermatol Surg"},{"key":"e_1_2_10_22_2","unstructured":"BurdickA SantosL. Dyshydrotic Eczema. URL:http:\/\/www.emedicine.com\/derm\/topic110.htm. Accessed January 2006 Copyright 2006 by WebMD."},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2002.00361.x"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124605"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-199712000-00006"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-200005000-00005"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2006.00255.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2006.00255.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:33:11Z","timestamp":1697038391000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2006.00255.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1473-2165.2006.00255.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2006.00255.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}